Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Ena-DATASET-SC-PP-10-12-2020-23:11:58:884-157 - samples

ABSTRACT: Pan Prostate Cancer Group UK BAM files

PROVIDER: EGAD00001006742 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.

Project description: Not available

| S-EPMC12507447 | biostudies-literature

Comparative genomic hybridization of Salmonella enteric serotype Newport strains from the US and UK to understand the emergence of highly virulent multi-drug resistant strains

Project description:Comparison between the multi-drug resistance Salmonella enteric serotype Newport strains from the US and the pan-susceptible strains from the UK

2009-10-02 | E-MEXP-1846 | biostudies-arrayexpress

6-Deoxy- and 11-Hydroxytolypodiols: Meroterpenoids from the Cyanobacterium HT-58-2.

Project description: Not available

| S-EPMC7246299 | biostudies-literature

ena-DATASET-UOMCAP-24-11-2020-23:19:59:840-777 - samples

Project description:Aligned whole-genome sequencing and RNA-seq of localised prostate cancer for study 'Loss of SNAI2 in prostate cancer correlates with clinical response to androgen deprivation therapy'.

| EGAD00001006640 | EGA

Pan-Prostate Cancer Group Bacterial Genome Recovery

Project description:Recovery of bacterial genomes from samples from the pan-prostate cancer group

| PRJEB72026 | ENA

Decarboxylation of the Catalytic Lysine Residue by the C5α-Methyl-Substituted Carbapenem NA-1-157 Leads to Potent Inhibition of the OXA-58 Carbapenemase.

Project description: Not available

| S-EPMC11972452 | biostudies-literature

Tetra-ethyl-ammonium 12-phenyl-ethynylcarba-closo-dodeca-borate, [Et(4)N][12-PhCC-closo-CB(11)H(11)].

Project description: Not available

| S-EPMC2977730 | biostudies-literature

PanProstate Cancer Group UK data

Project description:THE PAN PROSTATE CANCER PROJECT: Many groups around the world have generated Whole Genome DNA Sequence (WGS) data from prostate cancer patients. The pan prostate group have gathered with the idea that the accumulated data, should be collected and compared in a common format including common storage, re-analysis through a single pipeline, and investigation to achieve a variety of scientific goals. The combined collection would include the following categories: (i) cancers from different ethnic groups: eg Caucasian, Asian, Black Caribbean; (ii) cancer from different stages of progression from normal, to organ-confined disease, to metastases; (iii) early-onset prostate cancer; (iv) prostate cancer from aggressive and indolent disease; and (v) prostate cancer patients managed by different treatments with information linked to long-term clinical follow up data in many cases.This study contains the initial pilot samples (train 1) from the CRUK-ICGC prostate group.

| EGAS00001002876 | EGA

Do Maternal Living Arrangements Influence the Vaccination Status of Children Age 12-23 Months? A Data Analysis of Demographic Health Surveys 2010-11 from Zimbabwe.

Project description: Not available

| S-EPMC4500504 | biostudies-literature

Distinct genomic differences in prostate cancer between Western countries and China

Project description:The reason why prostate cancer is significantly more common in Western than Asian men is unknown. Using a genome-wide approach to compare the genomic changes in prostate cancer tissues, we determined that those from Chinese patients lack key somatic genomic changes commonly found in Western patients, including the 21q22.2-22.3 deletion which causes the TMPRSS2:ERG fusion gene, and 10q deletion which leads to PTEN inactivation. The results were confirmed and their consequence on ERG expression was identified by study of a large series of Chinese and UK samples using tissue-microarrays. Subsequently, we identified significant AR genotype differences between UK and Chinese prostate cancer patients. The identification of specific somatic genomic differences in cancers from distinct populations may provide an opportunity to identify cancer-causing or protective factors.

2010-05-15 | GSE18333 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data